0001021771-25-000134.txt : 20251009 0001021771-25-000134.hdr.sgml : 20251009 20251009125056 ACCESSION NUMBER: 0001021771-25-000134 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251009 DATE AS OF CHANGE: 20251009 EFFECTIVENESS DATE: 20251009 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioRestorative Therapies, Inc. CENTRAL INDEX KEY: 0001505497 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 301341024 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-560305 FILM NUMBER: 251384234 BUSINESS ADDRESS: STREET 1: 40 MARCUS DRIVE CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: (631) 760-8100 MAIL ADDRESS: STREET 1: 40 MARCUS DRIVE CITY: MELVILLE STATE: NY ZIP: 11747 FORMER COMPANY: FORMER CONFORMED NAME: Stem Cell Assurance, Inc. DATE OF NAME CHANGE: 20101110 D 1 primary_doc.xml X0708 D LIVE 0001505497 BioRestorative Therapies, Inc. 40 Marcus Drive Suite One Melville NY NEW YORK 11747 631-760-8100 NEVADA Traxxec Inc. Columbia River Resources Inc. Stem Cell Assurance, Inc. Corporation true Lance Alstodt c/o 40 Marcus Drive Suite One Melville NY NEW YORK 11747 Director Executive Officer Francisco Silva c/o 40 Marcus Drive Suite One Melville NY NEW YORK 11747 Director Executive Officer Robert Kristal c/o 40 Marcus Drive Suite One Melville NY NEW YORK 11747 Executive Officer David A Rosa c/o 40 Marcus Drive Suite One Melville NY NEW YORK 11747 Director Patrick F Williams c/o 40 Marcus Drive Suite One Melville NY NEW YORK 11747 Director Nickolay V Kukekov c/o 40 Marcus Drive Suite One Melville NY NEW YORK 11747 Director Biotechnology $1 - $1,000,000 06b false 2025-10-08 false true true true false 0 Cova Capital Partners LLC 109761 None None 6851 Jericho Tpke Suite 205 Syosset NY NEW YORK 11791 All States 1398628 1398628 0 false 16 0 0 The amounts shown above exclude the sales commissions payable in connection with the concurrent public offering relating to the offer and sale of shares of the Company's common stock. 0 The amounts shown above exclude the salaries and fees payable to the executive officers and directors in the ordinary course of business. false BioRestorative Therapies, Inc. /s/ Robert Kristal Robert Kristal Chief Financial Officer 2025-10-09